Two Sigma Securities’s Lipella Pharmaceuticals LIPO Stock Holding History

Two Sigma Securities’s Portfolio LIPO Stock Details LIPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,642	Closed	-$25.6K	–	3108
2023 Q1	$25.6K	Buy	+1,642	New	+$32.1K	﹤0.01%	2334

Other funds holding LIPO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Securities's LIPO Position: Q2 2023 in Review

Two Sigma Securities sold out of Lipella Pharmaceuticals (LIPO) in Q2 2023, closing a stake of 1,642 shares — an estimated $25.6K sold.

Two Sigma Securities first reported a position in LIPO in Q1 2023 and held it in 1 quarter. The position peaked at $25.6K in Q1 2023. 4 funds tracked by Wall St. Rank hold LIPO as of Q2 2023.

Two Sigma Securities reported no remaining Lipella Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Two Sigma Securities sold 1,642 Lipella Pharmaceuticals shares in Q2 2023, an estimated $25.6K.
Two Sigma Securities first reported a position in Lipella Pharmaceuticals in Q1 2023 and held it in 1 quarter.
Two Sigma Securities's Lipella Pharmaceuticals position peaked at $25.6K in Q1 2023.
4 funds tracked by Wall St. Rank held Lipella Pharmaceuticals as of Q2 2023.

Based on Two Sigma Securities's 13F filing for Q2 2023, filed 14 Aug 2023.